Iovance Biotherapeutics
IOVA
IOVA
85 hedge funds and large institutions have $429M invested in Iovance Biotherapeutics in 2017 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 37 increasing their positions, 20 reducing their positions, and 13 closing their positions.
Holders
85
Holders Change
+1
Holders Change %
+1.19%
% of All Funds
2.12%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.05%
New
14
Increased
37
Reduced
20
Closed
13
Calls
$178K
Puts
$254K
Net Calls
-$76K
Net Calls Change
-$3.32M
Top Buyers
1 |
O
1
OrbiMed
New York
|
$49.8M |
2 |
GPP
2
Great Point Partners
Greenwich,
Connecticut
|
$15.5M |
3 |
3
Millennium Management
New York
|
$16.1M |
4 |
FCM
4
Farallon Capital Management
San Francisco,
California
|
$6.59M |
5 |
![]()
5
JPMorgan Chase & Co
New York
|
$14.1M |